Search

Author/Creator Kolasa R. investigator.

1. Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate‐to‐Severe Rheumatoid Arthritis. Issue 1 (21st November 2017)

Authors:
Weinblatt, Michael E.; Baranauskaite, Asta; Niebrzydowski, Jaroslaw; Dokoupilova, Eva; Zielinska, Agnieszka; Jaworski, Janusz; Racewicz, Artur; Pileckyte, Margarita; Jedrychowicz‐Rosiak, Krystyna; Cheong, Soo Yeon; Ghil, Jeehoon
Other Names:
Sokolovic S. investigator.; Mekic M. investigator.; Prodanovic N. investigator.; Gajic B. investigator.; Karaselimovic‐Dzambasovic E. investigator.; Pojskic B. investigator.; Toncheva A. investigator.; Dimitar P. investigator.; Rodina L. investigator.; Geneva‐Popova M. investigator.; Staykov I. i...
Journal:
Arthritis & rheumatology
Issue:
Volume 70:Issue 1(2018)
Page Start:
40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search